EPO and anemia (phenotype): EPO treatment in extremely low birth weight infants appears to be well tolerated with no excess morbidity or mortality, and, in addition to improving anemia, is associated with overall benefit in developmental assessment and cognitive development (Fauchere et al., 2008; Juul et al., 2008; Neubauer et al., 2010; Fischer et al., 2017).